GlassScriptPhysician profile
Ryan Thomas Krafft
NPI 1356597330
$50,569.84
in general payments reported to CMS, 2019-2025
16 companies · $1,440 in 2025
The $1,440 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $5,417 · 2021: $8,146 · 2022: $8,322 · 2023: $13K · 2024: $329 · 2025: $1,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,925 · Food and Beverage: $2,437 · Consulting Fee: $1,913 · Travel and Lodging: $1,791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,925.00 |
| Food and Beverage | $2,436.56 |
| Consulting Fee | $1,912.50 |
| Travel and Lodging | $1,791.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $43,996.87 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Vertos Medical, INC. | $3,563.64 | 2019-2022 | |
| Medtronic, INC. | $1,974.61 | 2021-2025 | Kyphon Express II Kyphopak Tray, Inceptiv, Intellis Adaptivestim |
| Abbott Laboratories | $539.09 | 2019 | |
| Medtronic USA, INC. | $146.76 | 2019-2020 | |
| Baudax Bio INC. | $74.26 | 2021-2022 | |
| Abbvie INC. | $61.80 | 2025 | |
| Pfizer INC. | $47.02 | 2019-2021 | |
| Spr Therapeutics, INC | $35.65 | 2024 | Sprint Pns System |
| Daiichi Sankyo INC. | $29.95 | 2019 | |
| Nevro Corp. | $26.53 | 2020 | |
| Nalu Medical, INC. | $18.46 | 2023 | Nalu Neurostimulation System |
| Painteq LLC | $16.58 | 2024 | Painteq |
| Collegium Pharmaceutical, INC. | $15.58 | 2022 | |
| Midsouth Orthopedics INC. | $14.78 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $8.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Krafft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.